$7.77
0.22[2.91%]
Last update: 11:41AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$7.55
-0.2200[-2.83%]
| Open7.730 | Close- |
| Vol / Avg.65.988K / 398.262K | Mkt Cap341.107M |
| Day Range7.600 - 7.915 | 52 Wk Range4.775 - 14.340 |
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%
Voyager Therapeutics Stock (NASDAQ:VYGR), Key Statistics
Voyager Therapeutics Stock (NASDAQ: VYGR) analysis, key statistics.
Valuation Measures
Enterprise Value
80.4M
Trailing P/E
3.46
Forward P/E
- -
PE Ratio (TTM)
3.46
PEG Ratio (TTM)
- -
Price / Sales (ttm)
1.59
Price / Book (mrq)
1.67
Price / EBITDA
3.39
Enterprise Value / EBITDA (TTM)
0.88
Earnings Yield
28.87%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
4.53
Tangible Book value per share
4.53
Total Liabilities (Quarterly)
116.5M
Total Assets
315.5M
Total Liabilities
116.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
-457.61%
EBIT Margin
-523.92%
EBITDA Margin
-501.55%
Operating Margin
-523.92%